Study of SPARC1103 in Subjects With Spasticity
Public ClinicalTrials.gov record NCT02027025. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study of SPARC1103 in subjects with spasticity
Study identification
- NCT ID
- NCT02027025
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 142 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 21, 2014 (Actual)
- Primary completion
- Apr 28, 2017 (Actual)
- Completion
- Apr 28, 2017 (Actual)
- Last update posted
- May 3, 2019
2014 – 2017
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| SPARC Site 4 | Long Beach | California | — | — |
| SPARC Site 6 | San Diego | California | — | — |
| SPARC Site 10 | Aurora | Colorado | — | — |
| SPARC Site 2 | Jacksonville | Florida | — | — |
| SPARC Site 15 | Miami | Florida | — | — |
| SPARC Site 7 | Miami Springs | Florida | — | — |
| SPARC Site 5 | Orlando | Florida | — | — |
| SPARC Site 13 | Tampa | Florida | — | — |
| SPARC Site 11 | Kansas City | Kansas | — | — |
| SPARC Site 3 | Lenexa | Kansas | — | — |
| SPARC Site 1 | Bingham Farms | Michigan | — | — |
| SPARC Site 14 | Albuquerque | New Mexico | — | — |
| SPARC Site 9 | Charlotte | North Carolina | — | — |
| SPARC Site 8 | Cleveland | Ohio | — | — |
| SPARC Site 12 | Richland | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02027025, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 3, 2019 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02027025 live on ClinicalTrials.gov.